FDA Approves Symbravo for Acute Treatment of Migraine in Adults By Lori Solomon HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

And it works, according to one patient who took the drug during its trial period. Samantha, 50 ... Related: Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea The new drug is an ...

NEW YORK, Jan. 29 (Xinhua) -- The 2026 World Cup kicks off in less than 500 days and there is mounting concern that the United States is not ready to welcome the more than 6 million visitors who ...

Novo Nordisk (NYSE:NVO) just scored a game-changing FDA approval for Ozempic, expanding its use beyond diabetes to tackle chronic kidney disease and cardiovascular risks. The move solidifies ...

The 2026 World Cup kicks off in less than 500 days and there is mounting ... Among other things the bill, approved by Congress and sent to the president’s desk last week, gives individual states the ...

SoFi Stadium in Inglewood will host games during the 2026 World Cup and swimming during the 2028 Olympics. Long wait times for visa approvals could prevent fans from many countries from attending ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.

Emmanuel Macron’s approval ratings have plunged to their ... minister acts as an executor and “fuse”. However, in a period of “cohabitation” with the opposition, the head of state ...

as determined by a Food and Drug Administration (FDA)-approved test, that has progressed on one or more endocrine therapies in the metastatic setting. ENHERTU is a specifically engineered HER2 ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy. The Food and Drug ...